Pirenperone
Chemical compound
From Wikipedia, the free encyclopedia
Pirenperone (INN, USAN, BAN; developmental code names R-47456 and R-50656) is a serotonin receptor antagonist closely related to ketanserin and risperidone which is described as an antipsychotic and tranquilizer and was never marketed.[2][3]
| Clinical data | |
|---|---|
| Other names | R-47456; R-50656; Pirenpirone |
| Drug class | Serotonin 5-HT2A receptor antagonist |
| Pharmacokinetic data | |
| Elimination half-life | 4–6 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.071.081 |
| Chemical and physical data | |
| Formula | C23H24FN3O2 |
| Molar mass | 393.462 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
It is a relatively selective antagonist of the serotonin 5-HT2A receptor and has been used in scientific research to study the serotonin system.[4][3][5][6] Its affinities (Ki) for serotonin and other receptors have been reported to be 0.3 to 1.1 nM for the serotonin 5-HT2A receptor, 6.5 nM for the serotonin 5-HT7 receptor, 20 nM for the α1B-adrenergic receptor, 20 nM for the α2B-adrenergic receptor, 61 nM for the serotonin 5-HT2B receptor, 60 to 77 nM for the serotonin 5-HT2C receptor, 485 to 1,700 nM for the serotonin 5-HT1A receptor, and >1,000 or 6,600 nM for the serotonin 5-HT1B receptor, whereas other receptors were not reported.[4][6]
The elimination half-life of pirenperone has been said to be 4 to 6 hours.[1]
In the 1980s, the drug was found to block the effects of the lysergic acid diethylamide (LSD) in animals, and, along with ketanserin, led to the elucidation of the 5-HT2A receptor as the biological mediator of the effects of serotonergic psychedelics.[7] Along similar lines, there has been interest in pirenperone for potential use as a trip killer against psychedelics in humans.[1]